Position in ACB
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$2
-$1 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#140
of 149 holders
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GILL CAPITAL PARTNERS, LLC holds $7,200 across 6 Drug Manufacturers - Specialty & Generic names. ACB ranks #6 (0.0% of the industry book) .
All Filings in ACB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2 | 1 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $3 | 1 | Shares | Sole | 2026-04-13 | |
| 2023-03-31 | $19,494 | 27,969 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $23,969 | 25,969 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $21,974 | 18,012 | Shares | Sole | 2022-10-19 | |
| No filing history on record for this holder in this stock. | ||||||